SINGAPORE (AP) _ Wave Life Sciences Pte. Ltd. (WVE) on Friday reported a loss of $37.6 million in its third quarter.
The Singapore-based company said it had a loss of $1.28 per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.25 per share.
The biopharmaceutical company posted revenue of $4.5 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $5.4 million.
Wave Life Sciences shares have climbed 29 percent since the beginning of the year. The stock has more than doubled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WVE at https://www.zacks.com/ap/WVE